ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Cancergrams Cost $840 Year For All

December 2, 1977

NCI’s Weinstein Said He Never Pressured Researcher

November 3, 1995

Sharon Murphy To Head New Research Center in San Antonio

August 2, 2002

ACS Honors Cady, Rimer For Work In Cancer Control.

December 8, 2000

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999